Preclinical cardiac disease in nonalcoholic fatty liver disease with and without metabolic syndrome.

Metabolic syndrome is associated with preclinical cardiac disease and nonalcoholic fatty liver disease (NAFLD). It is uncertain whether preclinical cardiac disease is present in patients with NAFLD without metabolic syndrome (MetS).To explore preclinical cardiac disease in patients with NAFLD.A total of 64 patients with NAFLD, based on computed tomography scans liver attenuation, were identified. A control group, matched to age and gender,...